Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2010 /
Exploiting cancer stress for new therapies

8th - 12th Dec 2010

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.01.11
Views: 6357
Rating:

Prof Garth Powis – MD Anderson Cancer Centre, Houston, USA

Prof Garth Powis talks to ecancertv at the 2010 San Antonio Breast Cancer Symposium about how causing stress to tumours by increasing hypoxia to reduce tumour resistance to chemotherapy and radiotherapy. Increase in glycolytic enzymes stimulates hypoxia (decreased blood flow to tumour). Increased hedgehog signalling produces desmoplasia (fibrosis of tumours) which can also stimulate hypoxia and start a cycle of further increased hedgehog signalling. This cycle can potentially be jump started using HIF inhibitors (in this case PX-478).

Categories:

Breast · Drug development · SABCS 2010

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation